Bullish Moving Averages
11
Bearish Moving Averages
0
Back Stocks profile
Open Price
1059.90Prev. Close
1040.0000Volume
226107.00Value
250526556.00Market Cap Cr
4819.10
Price to Earnings
123.20
Price to Book Value
2.90
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
3922.31
Net Profit TTM Cr
39.11
Cash From Operating Activity Cr
-36.61
Return on Equity %
2.38
EMA & SMA
Bullish Moving Averages
11
Bearish Moving Averages
0
DELIVERY AND VOLUME
02 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
1064.17
Second Resistance
1081.08
Third Resistance
1092.17
First Support
1036.17
Second Support
1025.08
Third Support
1008.17
Relative Strength Index
50.11
Money Flow Index
59.88
MACD
2.37
MACD Signal
0.01
Average True Range
28.2
Average Directional Index
13.55
Rate of Change (21)
1.84
Rate of Change (125)
Commodity Channel Index
55.1
Williams %R
-46.9
BETA
1 Month
0.06
3 Month
-0.02
1 Year
3 Year
PRICE CHANGE ANALYSIS
1 Week
Low
High
1031.6
1122.75
1 Month
Low
High
991.1
1122.75
3 Months
Low
High
985.35
1225
6 Months
Low
High
970
1258
1 Year
Low
High
970
1258
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Acquisition
Entero Healthcare Solutions Limited ("Entero") has informed the Exchange about acquisition of Devi Pharma Wellness Private Limited approved by the Board of Entero at its meeting held on June 28, 2024.Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting Held On June 28, 2024
Outcome of Board Meeting held on June 28, 2024Entero Healthcare Solutions Ltd - 544122 - Closure of Trading Window
Trading Window Closure NoticeEntero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015- Transcript of Earnings Call / Conference call .Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meeting (Group Meeting) to be held on June 07, 2024 under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdEntero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Investor Presentation
Corrigendum to the Investor Presentation on the audited financial results of the Company for the quarter and year ended March 31, 2024.Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies news paper advertisements published on May 31, 2024 in Financial Express and Satyajay Times providing extract of financial results for the quarter and year ended March 31, 2024.Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Recording of Earnings Call/ Conference CallThe latest market price of Entero Healthcare Solutions Ltd. on NSE was Rs. 1108.00 as of today.
The opening share price of Entero Healthcare Solutions Ltd. was Rs. 1059.90 as of today.
The 52-week high share price of Entero Healthcare Solutions Ltd. was Rs. 1258.00.
The 52 week low share price of Entero Healthcare Solutions Ltd. was Rs. 970.00.
Entero Healthcare Solutions Ltd. has a market cap of Rs. 4819.10 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Entero Healthcare Solutions Ltd. is 0.00. Please refer to the Fundamentals section for further details.
The operating revenue for Entero Healthcare Solutions Ltd. in the last FY was Rs. 3922.31 crore. Please refer to the Financials section for further details.
The Net Profit for Entero Healthcare Solutions Ltd. in the last FY was Rs. 39.11 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Entero Healthcare Solutions Ltd..